Browse by all authors Browse By Author ID - Lisa Nicole Putral

Browse Results (10 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Wu, Sherry Y., Putral, Lisa N., Liang, Mingtao, Chang, Hsin-I, Davies, Nigel M. and McMillan, Nigel A.J. (2009) Development of a novel method for formulating stable siRNA-loaded lipid particles for In vivo use. Pharmaceutical Research, 26 3: 512-522. doi:10.1007/s11095-008-9766-1 75   22 Cited 21 times in Scopus21 0
Trezise, A. E. O., Shaddock, N., Putral, L., Bain, N. L. and Murdoch, B. E. (2003). High levels of Myf5 & MyoD direct expression of the extraocular-myosin heavy chain in laryngeal muscles & regenerating muscle. In: 24th Annual Lorne Conference on the Organization and Expression of the Genome, Lorne, Victoria, Australia, (). 16-20 February 2003. 45  
Gu, W., Putral, L., Hengst, K., Minto, K., Saunders, N. A., Leggatt, G. and McMillan, N. A. J. (2006) Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes. Cancer Gene Therapy, 13 11: 1023-1032. doi:10.1038/sj.cgt.7700971 180   69 Cited 72 times in Scopus72 0
Putral, L. N., Bywater, M. J., Gu, W. Y., Saunders, N. A., Gabrielli, B. G., Leggatt, G. R. and McMillan, N. A. J. (2005) RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Molecular Pharmacology, 68 5: 1311-1319. doi:10.1124/mol.105.014191 91   60 Cited 69 times in Scopus69 0
Putral, Lisa N., Gu, Wenyi and McMillan, Nigel A. J. (2006) RNA interference for the treatment of cancer. Drug News & Perspectives, 19 6: 317-324. doi:10.1358/dnp.2006.19.6.985937 120   19 Cited 20 times in Scopus20 0
Hirani, Rena, Connolly, Ashley R., Putral, Lisa, Dobrovic, Alexander and Trau, Matt (2011) Sensitive quantification of somatic mutations using molecular inversion probes. Analytical Chemistry, Articles ASAP 21: 8215-8221. doi:10.1021/ac2019409 46   3 Cited 2 times in Scopus2 0
Gu, W., Putral, L. and McMillan, N. A. J. (2008). siRNA and shRNA as anti-cancer agents in a cervical cancer model. In J. M. Walker (Ed.), RNAi : design and application (pp. 159-172) Totowa, N.J., U.S.A.: Humana Press, Inc.. 105  
Wu, S. Y., Singhania, A., Burgess, M., Putral, L. N., Kirkpatrick, C., Davies, N. M. and McMillan, N. A. J. (2011) Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models. Gene Therapy, 18 1: 14-22. doi:10.1038/gt.2010.113 93 60 21 Cited 21 times in Scopus21 0
Gu, W. Y., Putral, L. N., Irving, A. and McMillan, N. A. J. (2007) The development and future of oligonucleotide-based therapies for cervical cancer. Current Opinions in Molecular Therapeutics, 9 2: 126-131. 99   9 Cited 9 times in Scopus9
Putral, Lisa (2007). TREATMENT OF CERVICAL CANCER USING RNA-INTERFERENCE AGAINST HUMAN PAPILLOMAVIRUS ONCOGENES PhD Thesis, School of Medicine, University of Queensland. 428 11